Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide.
| Website | http://www.vorbio.com |
| Revenue | $124.8 million |
| Employees | 111 (1 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Hematopoietic Stem Cell, Blood Cancer Treatment, Genome Engineering, Cell Engineering, Stem Cell Therapy, Targeted Therapies, Cell Therapy, Cancer Immunotherapy, Clinical Stage Biotech, Gene Editing, Hematology, Oncology, Biotechnology, Transplantation, Post Transplant Care, Immuno Oncology, Regenerative Medicine, Precision Medicine, Drug Development, Clinical Trials |
| Competitors | Intellia Therapeutics, Inc., CRISPR Therapeutics, bluebird bio, CureVac, Editas Medicine, Rocket Pharmaceuticals, REGENXBIO Inc., Sangamo Therapeutics, Inc., Audentes Therapeutics, Abeona Therapeutics +39 more (view full list) |
Looking for a particular Vor Bio employee's phone or email?
Vor Bio Questions
The Vor Bio annual revenue was $124.8 million in 2026.
Tania Philipp is the Chief People Officer of Vor Bio.
1 people are employed at Vor Bio.
Vor Bio is based in Cambridge, Massachusetts.
Top Vor Bio Employees
-
Tania Philipp
Chief People Officer at Vor Bio
United States35+
Related Companies
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups.
Search the #1
Contact Database
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Use our
AI-Powered
Email Finder
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.
G2Crowd Trusted
300K+
Plugin Users
